David Arranz-Solís

Dr. David Arranz-Solís

Animal Health, Complutense University of Madrid, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2020 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
DMDebanjan Mukhopadhyay
Debanjan Mukhopadhyay
David Arranz-SolísDavid Arranz-Solís
David Arranz-Solís
JSJeroen P. J. Saeij
Jeroen P. J. Saeij
Toxoplasma gondii is an exceptionally successful parasite that infects a very broad host range, including humans, across the globe. The outcome of infection differs remarkably between hosts, ranging from acute death to sterile infection. These differential disease patterns are strongly influenced by both host- and parasite-specific genetic factors. In this review, we discuss how the clinical outcome of toxoplasmosis varies between hosts and the role of different immune genes and parasite virulence factors, with a special emphasis on Toxoplasma-induced ileitis and encephalitis.

1 January 2014 in Veterinary Research
Verified
Journal Article
Open access
PDF file
JRJavier Regidor-Cerrillo
Javier Regidor-Cerrillo
David Arranz-SolísDavid Arranz-Solís
David Arranz-Solís
JBJulio Benavides
Julio Benavides
MGMercedes Gómez-Bautista
Mercedes Gómez-Bautista
CACastro-Hermida José Antonio
Castro-Hermida José Antonio
MGMarta González-Warleta
Marta González-Warleta
This work studies the influence of Neospora caninum intra-species diversity on abortion outcome, infection dynamics in terms of parasite dissemination and peripheral-local immune responses in pregnant cattle. Animals were intravenously inoculated at day 70 of pregnancy with 107 tachyzoites of two isolates showing marked differences in virulence in vitro and in pregnant mouse models: Nc-Spain7, a high virulence isolate, and Nc-Spain8, a low-to-moderate virulence isolate. After inoculation, pregnancy was monitored, and dams were culled when foetal death was detected. Foetal mortality occurred in all infected heifers between days 24 and 49 post-infection (pi), however, it was detected sooner in Nc-Spain7-infected animals (median day = 34) than those inoculated with Nc-Spain8 (median day = 41) with a trend towards significance (P < 0.11). Similar histological lesions were observed in placentomes and in most of the foetuses from the two infected groups. However, parasites were more frequently detected in the placenta and foetuses by PCR and in the foetal brain by immunohistochemistry in Nc-Spain7-infected animals. Specific antibodies were detected starting at day 13 post-infection in all infected cattle, with higher IgG levels in Nc-Spain7-infected group. IFN-γ and IL-4 profiles also varied between infected groups in PBMC stimulation assays. Infected animals showed significant increases in their cytokine mRNA levels (IFN-γ, IL-4, IL-10, IL-12p40 and TNF-α) in the caruncle at time of foetal death. Differences between the infected groups were also observed for cytokine profiles. These results demonstrate the influence of the N. caninum isolate on foetal death outcome, infection dynamics and immune responses in cattle.

26 May 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
DMDebanjan Mukhopadhyay
Debanjan Mukhopadhyay
David Arranz-SolísDavid Arranz-Solís
David Arranz-Solís
JSJeroen P. J. Saeij
Jeroen P. J. Saeij
The murine innate immune response against Toxoplasma gondii is predominated by the interaction of TLR11/12 with Toxoplasma profilin. However, mice lacking Tlr11 or humans, who do not have functional TLR11 or TLR12, still elicit a strong innate immune response upon Toxoplasma infection. The parasite factors that determine this immune response are largely unknown. Herein, we investigated two dense granule proteins (GRAs) secreted by Toxoplasma, GRA15 and GRA24, for their role in stimulating the innate immune response in Tlr11-/- mice and in human cells, which naturally lack TLR11/TLR12. Our results show that GRA15 and GRA24 synergistically shape the early immune response and parasite virulence in Tlr11-/- mice, with GRA15 as the predominant effector. Nevertheless, acute virulence in Tlr11-/- mice is still dominated by allelic combinations of ROP18 and ROP5, which are effectors that determine evasion of the immunity-related GTPases. In human macrophages, GRA15 and GRA24 play a major role in the induction of IL12, IL18 and IL1β secretion. We further show that GRA15/GRA24-mediated IL12, IL18 and IL1β secretion activates IFNγ secretion by peripheral blood mononuclear cells (PBMCs), which controls Toxoplasma proliferation. Taken together, our study demonstrates the important role of GRA15 and GRA24 in activating the innate immune response in hosts lacking TLR11. In mice, the early immune response against Toxoplasma is dominated by TLR11-mediated release of IL12, which subsequently induces protective IFNγ. Here we show that in Tlr11-/- mice and in human cells, which do not have TLR11, the Toxoplasma GRA15 and GRA24 effectors play an important role in induction of IL12, IL18 and IL1β, and thus in the subsequent protective IFNγ secretion.

1 April 2021 in Trends in Parasitology
Verified
Journal Article
Closed access
David Arranz-SolísDavid Arranz-Solís
David Arranz-Solís
DMDebanjan Mukhopadhyay
Debanjan Mukhopadhyay
JSJeroen J.P. Saeij
Jeroen J.P. Saeij

1 April 2015 in International Journal for Parasitology: Drugs and Drug Resistance
Verified
Journal Article
Open access
JMJoachim Müller
Joachim Müller
AAAdriana Aguado-Martinez
Adriana Aguado-Martinez
VMVera Manser
Vera Manser
VBVreni Balmer
Vreni Balmer
PWPablo Winzer
Pablo Winzer
Andrew HemphillAndrew Hemphill
Andrew Hemphill
The naphthoquinone buparvaquone is currently the only drug used against theileriosis. Here, the effects of buparvaquone were investigated in vitro and in an experimental mouse model for Neospora caninum infection. In 4-day proliferation assays, buparvaquone efficiently inhibited N. caninum tachyzoite replication (IC50 = 4.9 nM; IC100 = 100 nM). However, in the long term tachyzoites adapted and resumed proliferation in the presence of 100 nM buparvaquone after 20 days of cultivation. Parasiticidal activity was noted after 9 days of culture in 0.5 µM or 6 days in 1 µM buparvaquone. TEM of N. caninum infected fibroblasts treated with 1 µM buparvaquone showed that the drug acted rather slowly, and ultrastructural changes were evident only after 3-5 days of treatment, including severe alterations in the parasite cytoplasm, changes in the composition of the parasitophorous vacuole matrix and a diminished integrity of the vacuole membrane. Treatment of N. caninum infected mice with buparvaquone (100 mg/kg) either by intraperitoneal injection or gavage prevented neosporosis symptoms in 4 out of 6 mice in the intraperitoneally treated group, and in 6 out of 7 mice in the group receiving oral treatment. In the corresponding controls, all 6 mice injected intraperitoneally with corn oil alone died of acute neosporosis, and 4 out of 6 mice died in the orally treated control group. Assessment of infection intensities in the treatment groups showed that, compared to the drug treated groups, the controls showed a significantly higher parasite load in the lungs while cerebral parasite load was higher in the buparvaquone-treated groups. Thus, although buparvaquone did not eliminate the parasites infecting the CNS, the drug represents an interesting lead with the potential to eliminate, or at least diminish, fetal infection during pregnancy.

1 July 2015 in Veterinary Parasitology
Verified
Journal Article
Closed access
David Arranz-SolísDavid Arranz-Solís
David Arranz-Solís
AAAdriana Aguado-Martínez
Adriana Aguado-Martínez
JMJoachim Müller
Joachim Müller
JRJavier Regidor-Cerrillo
Javier Regidor-Cerrillo
LOLuis Miguel Ortega-Mora
Luis Miguel Ortega-Mora
Andrew HemphillAndrew Hemphill
Andrew Hemphill